 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This is a signal that VNDA's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Vanda Pharmaceuticals (VNDA, $4.46) RSI Indicator left the oversold zone on September 18, 2023

Profit Investment Management LLC decreased its position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA  Free Report) by 1.3% during the 2nd quarter, Holdings Channel reports. The firm owned...

Profit Investment Management LLC Sells 4,195 Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

Vanda Pharmaceuticals (VNDA, $4.75) RSI Indicator left the oversold zone on September 13, 2023

VNDA's total volume now sits at 1.4M. The +3.94% average daily price change was insignificant these 4 days, leaving VNDA's price at $4.75...

The volume for Vanda Pharmaceuticals stock increased for four consecutive days, resulting in a record-breaking daily growth of 98% of the 65-Day Volume Moving Average

Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference PR...

Vanda Pharmaceuticals Announces Participation in the H.C. Wainwright Global Investment Conference

Principal Financial Group Inc. reduced its position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA  Free Report) by 1.4% in the first quarter, according to the company in its most recent filing...

Principal Financial Group Inc. Decreases Stock Position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

Russell Investments Group Ltd. trimmed its position in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA  Free Report) by 66.4% during the first quarter, according to its most recent disclosure with...

Russell Investments Group Ltd. Has $280,000 Holdings in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

This is a Bearish indicator signaling VNDA's price could decline from here. Traders may explore shorting the stock or put options...

Vanda Pharmaceuticals (VNDA, $5.58) Moving Average Convergence Divergence (MACD) Histogram turned negative on August 25, 2023

E Fund Management Co. Ltd. bought a new stake in Vanda Pharmaceuticals Inc. (NASDAQ:VNDA Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 13,060 shares of the biopharmaceutical companys stock, valued at approximately $89,000. ...

E Fund Management Co. Ltd. Acquires Shares of 13,060 Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

Pictet Asset Management SA grew its stake in shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA  Free Report) by 166.7% in the first quarter, HoldingsChannel.com reports. The fund owned 1,217,817 shares of the biopharmaceutical companys stock after acquiring an additional 761,200 shares...

Pictet Asset Management SA Purchases 761,200 Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Watchers	2,063
52-Wk Low	$4.15
52-Wk High	$11.04

Market Cap	$267.42M
Volume (M)	1.18M
52-Wk High	$11.04
52-Wk Low	$4.15

VNDA Vanda Pharmaceuticals Inc

About

Feed

News

Sentiment

Earnings

Fundamentals